About Jagsonpal Pharmaceuticals Ltd 
Jagsonpal Pharmaceuticals Ltd
Small Cap
Pharmaceuticals & Drugs
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.
Company Coordinates 
Company Details
T-210 J, Shahpur Jat New Delhi New Delhi : 110049
Registrar Details
MCS Ltd , F-65, , Okhla Industrial Area, Phase - I, New Delhi
Capital Structure 
Present Equity Capital
INR 13.27 Cr
Number of Shares
6.64 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Jan-2025
6.64
13.27
39818943
2
Stock Split
04-May-2024
2.64
13.22
3000
5
Issued under ESOP Scheme
29-Mar-2024
2.64
13.22
100000
5
Issued under ESOP Scheme
04-Jan-2024
2.63
13.17
50000
5
Issued under ESOP Scheme
04-Dec-2023
2.63
13.14
89794
5
Issued under ESOP Scheme
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 14 FIIs (2.1%)
Promoter with highest holding
Aresko Progressive Private Limited (20.09%)
Highest Public shareholder
Authum Investment And Infrastructure Limited (1.46%)
Individual Investors Holdings
20.64%
Management
Designation
Remuneration
Manish Gupta
Managing Director
1.06 cr
Harsha Raghavan
Chairman & Non Executive Dir.
0
Debasis Bikash Nandy
Independent Director
10.8 lacs
Radhika Dudhat
Independent Director
9.5 lacs
Pallavi Dinodia
Independent Director
10.0 lacs
Prithipal Singh Kochhar
Non Executive Director
0
Abhishek Joshi
Company Sec. & Compli. Officer
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical Goods
126.60
100.00%
Pharmaceutical Goods
Revenue and Profits:
Net Sales:
74 Cr
(Quarterly Results - Dec 2024)
Net Profit:
32 Cr
Pharmaceuticals & Drugs
INR 1,421 Cr (Small Cap)
38.00
33
0.99%
-0.35
18.07%
6.80